Toso Laura, Johnson Andrea, Bissell Stephanie, Roberson Robin, Abebe Daniel, Spong Catherine Y
Unit on Perinatal and Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Am J Obstet Gynecol. 2007 Sep;197(3):267.e1-4. doi: 10.1016/j.ajog.2007.05.049.
The administration of neurotrophic peptides NAPVSIPQ (NAP) + SALLRSIPA (SAL) to aged mice resulted in significant learning enhancement. N-methyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA) receptors are fundamental for learning because they are the major modulators of the long-term potentiation, the electrophysiologic mechanism for learning. Also, these receptors have been shown to be involved in NAP + SAL prevention of learning deficit in a mouse model for fetal alcohol syndrome, when administered prenatally during development. Our objective was to test whether NMDA and GABA receptors contribute to the learning enhancement that is induced by the peptides after adult administration.
Aged (14.5 months) male mice were treated for 10 consecutive days with placebo or D-NAP + D-SAL (20 microg, by gavage). At the end of the treatment, brains were harvested. Calibrator-normalized relative real-time polymerase chain reaction was performed with primers for GABA-(A)beta3, GABA-(A)alpha5, and the NMDA receptor subunits NR2A and NR2B, with GAPDH standardization. Statistical analysis included analysis of variance, with a probability value that was considered significant at <.05.
Five control brains and 6 brains from animals that were treated with NAP + SAL were collected. There was no difference in GABA-(A)beta3, GABA-(A)alpha5, NR2A, and NR2B subunits after adult administration of NAP + SAL, as compared with the controls (P > .05).
Postnatal treatment with NAP + SAL induced learning enhancement in aged mice with a mechanism that does not involve alteration in NMDA and GABA receptor expression. Thus, the mechanism of learning enhancement might be different for a developing fetus than an adult or in the absence of a perturbing agent.
向老年小鼠施用神经营养肽NAPVSIPQ(NAP)+ SALLRSIPA(SAL)可显著增强学习能力。N-甲基-D-天冬氨酸(NMDA)和γ-氨基丁酸(GABA)受体对学习至关重要,因为它们是长期增强作用(学习的电生理机制)的主要调节因子。此外,在发育过程中进行产前给药时,这些受体已被证明参与了在胎儿酒精综合征小鼠模型中NAP + SAL对学习缺陷的预防作用。我们的目的是测试NMDA和GABA受体是否有助于成年给药后肽诱导的学习增强。
14.5月龄的老年雄性小鼠连续10天接受安慰剂或D-NAP + D-SAL(20微克,通过灌胃)治疗。治疗结束时,采集大脑。使用GABA-(A)β3、GABA-(A)α5以及NMDA受体亚基NR2A和NR2B的引物进行校准归一化相对实时聚合酶链反应,并以甘油醛-3-磷酸脱氢酶(GAPDH)进行标准化。统计分析包括方差分析,概率值<0.05被认为具有显著性。
收集了5个对照大脑和6个接受NAP + SAL治疗的动物的大脑。与对照组相比,成年小鼠施用NAP + SAL后,GABA-(A)β3、GABA-(A)α5、NR2A和NR2B亚基没有差异(P>0.05)。
出生后用NAP + SAL治疗可使老年小鼠学习能力增强,其机制不涉及NMDA和GABA受体表达的改变。因此,发育中的胎儿与成年人或在没有干扰因素的情况下,学习增强的机制可能不同。